Gemcitabine/Cisplatin±Sorafenib for the First-Line Treatment of Chemonaive Chinese Patients with Advanced, Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Subgroup Analysis of the Phase III NExUS Trial

被引：0
|
作者：
Liao, Meilin [1 ]
Zhang, Li [2 ]
Sun, Yan [3 ]
Yu, Shiying [3 ]
Pan, Hongming [4 ]
Zhou, Caicun
Jiang, Anastasia
Montegriffo, Elaine
Ong, Teng Jin
Gatzemeier, Ulrich [5 ]
机构：
[1] Shanghai Chest Hosp, Clin Med Ctr Lung Tumor, Dept Pulm Oncol, Shanghai, Peoples R China
[2] Sun Yat Sen Univ, Dept Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Tongji Hosp, Dept Oncol, Shanghai, Peoples R China
[4] Sir Run Run Shaw Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [2] SORAFENIB (S) plus GEMCITABINE/CISPLATIN (GC) VS GC ALONE IN THE FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PHASE III NSCLC RESEARCH EXPERIENCE UTILIZING SORAFENIB (NEXUS) TRIAL
    Gatzemeier, U.
    Eisen, T.
    Santoro, A.
    Paz-Ares, L.
    Bennouna, J.
    Liao, M.
    Strauss, U. P.
    Montegriffo, E.
    Ong, T. J.
    Biesma, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 7 - 7
  • [3] Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer
    Wu, Yi-Long
    Lu, Shun
    Cheng, Ying
    Zhou, Caicun
    Wang, Mengzhao
    Qin, Shukui
    Lu, You
    Zhang, Yang
    Zhu, Yunzhong
    Song, Xiangqun
    Wang, Xin
    Barraclough, Helen
    Zhang, Xiaoqing
    Chi, Haidong
    Orlando, Mauro
    LUNG CANCER, 2014, 85 (03) : 401 - 407
  • [4] A phase II trial of adding cetuximab to cisplatin and gemcitabine as first-line therapy in advanced non-small cell lung cancer (NSCLC)
    Barata, F.
    Parente, B.
    Teixeira, E.
    Costa, A.
    Fernandes, A.
    Pimentel, F. L.
    Carvalho, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer Results of an Exploratory Subgroup Analysis of a Phase III Trial
    Yang, Chih-Hsin
    Simms, Lorinda
    Park, Keunchil
    Lee, Jin Soo
    Scagliotti, Giorgio
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 688 - 695
  • [6] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [7] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    Wachters, FM
    van Putten, JWG
    Kramer, H
    Erjavec, Z
    Eppinga, P
    Strijbos, JH
    de Leede, GPJ
    Boezen, HM
    de Vries, EGE
    Groen, HJM
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1192 - 1199
  • [8] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    F M Wachters
    J W G van Putten
    H Kramer
    Z Erjavec
    P Eppinga
    J H Strijbos
    G P J de Leede
    H M Boezen
    E G E de Vries
    H J M Groen
    British Journal of Cancer, 2003, 89 : 1192 - 1199
  • [9] Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer
    Paz-Ares, Luis G.
    Biesma, Bonne
    Heigener, David
    von Pawel, Joachim
    Eisen, Timothy
    Bennouna, Jaafar
    Zhang, Li
    Liao, Meilin
    Sun, Yan
    Gans, Steven
    Syrigos, Kostas
    Le Marie, Etienne
    Gottfried, Maya
    Vansteenkiste, Johan
    Alberola, Vincente
    Strauss, Uwe Phillip
    Montegriffo, Elaine
    Ong, Teng Jin
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3084 - 3092
  • [10] Randomized phase III trial of gemcitabine/cisplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLC)
    Manegold, C.
    Thatcher, N.
    Benner, R. J.
    Readett, D.
    van Zandwijk, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345